Sixteen Swiss hospitals take part in coronavirus global Solidarity trial
University Hospital Lausanne is coordinating the trial in Switzerland.
Keystone / Laurent Gillieron
Some 1,000 patients in Switzerland are expected to participate in trials of experimental treatments for Covid-19 as part of the WHO global Solidarity trial.
Launched in March under the auspices of the World Health Organisation, the Solidarity trialExternal link aims to generate reliable data on the effectiveness and side effects of potential treatments.
While randomized clinical trials normally take years to design and conduct, the Solidarity trial is expected to reduce the time by 80% by enrolling patients in one single randomized trial. This will overcome the risk of multiple small trials not generating strong enough evidence.
The WHO has selected four therapies for testing based on laboratory, animal and clinical studies evidence of their potential to treat Covid-19. This includes remdesivir, chloroquine or hydroxychloroquine, lopinavir plus ritonavir, and interferon-beta. Novartis recently announced it was donating up to 130 million doses of the antimalarial drug hydroxychloroquine in part to advance clinical trials.
Switzerland is one of some 70 countries participating in the effort along with France, Spain, South Africa and Canada. The Swiss National Science Foundation (SNSF) has provided CHF1.6 million to the global trial and is working closely with the Federal Office of Public Health. Lausanne University Hospital CHUV is coordinating Switzerland’s participation in the tiral.
The sixteen hospital centres are the university hospitals of Lausanne, Geneva, Bern and Basel, the hospital networks of Valais and Neuchâtel, along with several cantonal hospitals. The hospitals are expected to recruit up to 1,000 patients to take part in the study according to a statementExternal link from CHUV.
The trial in Switzerland is expected to last from three months to one year but will depend in part on the evolution of the epidemic. The study may include up to 1,000 adult hospitalized patients who have not yet received treatment with Covid-19.
According to the WHOExternal link, patients diagnosed with COVID-19 and who have consented to be part of the study will be randomly selected to receive either local standard care alone or local standard care and one of a list of study drugs.
SNSF also announced that it has received 284 grant applicationsExternal link for its special call for coronavirus research issued in March. Funding decisions are expected to be communicated around mid-May 2020.
Popular Stories
More
Swiss Abroad
Heimatort, sweet Heimatort: the unique Swiss concept of home
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
This content was published on
French and Swiss armoured and artillery units will train together to strengthen the defence capabilities of the Swiss army.
Harmful substances in particulate matter underestimated: Swiss research
This content was published on
Measurements significantly underestimate the amount of harmful substances in particulate matter, says an international research team under Swiss leadership.
Switzerland reopens its humanitarian office in Kabul
This content was published on
Switzerland opened its humanitarian office in Kabul in mid-March to provide targeted aid to the Afghan population in distress.
This content was published on
From Wednesday, a Swiss passport will no longer be sufficient to enter the UK - Swiss travellers will also need an electronic travel authorisation.
This content was published on
A German security expert could imagine Swiss soldiers being part of a peacekeeping force in Ukraine after an eventual ceasefire.
Leading Swiss politician favours closer EU defence ties
This content was published on
Co-president of Swiss centre-left Social Democratic Party calls on Switzerland to step up security cooperation in Europe.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
WHO and Roche launch trials of potential coronavirus treatments
This content was published on
Roche is launching a clinical trial of a potential new Covid-19 drug, adding to rapidly growing investments in combating coronavirus.
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies' balancing act between hope and scientific realities.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.